Yiqing Wang - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Yiqing Wang's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Yiqing Wang

Yiqing Wang

Verified

Reporter, The Cancer Letter

Washington

Final Covers

US breaking news and local news in New York CityInternational

Doesn’t Cover

Journalist Type

-

Seniority Positions

-

Industries

Medium Formats

-

Content

Total articles 2

  • After a lifetime outside politics, an artist chooses his side: Trump

    By Yiqing Wang

    Apr. 08, 2024

  • House Committee attacks Biden’s border policies

    By Yiqing Wang

    Apr. 04, 2024

  • After a lifetime outside politics, an artist chooses his side: Trump

    By Yiqing Wang

    Apr. 08, 2024

As seen in

Company Info

The Cancer Letter

The Cancer Letter is an independent weekly news publication that focuses on cancer research, drug development, healthcare policy, and legislative issues in oncology. Founded in 1973 by journalist Jerry D. Boyd, it has established itself as a leading authority in oncology journalism, known for its investigative reporting and editorial independence. The publication transitioned to a fully digital format in 2008 and is based in Washington, D.C. The Cancer Letter offers a core publication that includes weekly issues covering various aspects of oncology. It features the Clinical Cancer Letter, which provides clinicians with trial data, treatment guidelines, and practice updates. The publication also includes guest editorials that highlight community perspectives, particularly during significant events like the COVID-19 pandemic. With over 200 institutional subscribers, including academic medical centers and research institutions, it serves approximately 40,000 professionals in the oncology field.

Washington, District of Columbia, United States

+1 202-362-1809

Founded: 1973